Daniel Grosslight

Stock Analyst at Citigroup

(1.17)
# 3,757
Out of 5,042 analysts
106
Total ratings
34.92%
Success rate
-13.03%
Average return

Stocks Rated by Daniel Grosslight

Claritev
Oct 22, 2025
Upgrades: Buy
Price Target: $55$74
Current: $69.69
Upside: +6.18%
Teladoc Health
Oct 21, 2025
Maintains: Neutral
Price Target: $9.5$11
Current: $9.46
Upside: +10.99%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $820$860
Current: $801.67
Upside: +7.28%
Owens & Minor
Aug 12, 2025
Maintains: Buy
Price Target: $11$7
Current: $5.51
Upside: +27.04%
Health Catalyst
Aug 8, 2025
Downgrades: Neutral
Price Target: $6.5$3.5
Current: $3.22
Upside: +8.70%
agilon health
Aug 6, 2025
Downgrades: Neutral
Price Target: $3$1
Current: $0.97
Upside: +3.10%
Waystar Holding
Jun 25, 2025
Initiates: Buy
Price Target: $45
Current: $38.97
Upside: +15.47%
Cardinal Health
Jun 13, 2025
Maintains: Neutral
Price Target: $157$170
Current: $161.89
Upside: +5.01%
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25$30
Current: $48.78
Upside: -38.50%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21$18
Current: $7.81
Upside: +130.47%
Maintains: Buy
Price Target: $7$6.25
Current: $3.95
Upside: +58.23%
Maintains: Buy
Price Target: $31$35
Current: $23.48
Upside: +49.06%
Initiates: Buy
Price Target: $25
Current: $25.99
Upside: -3.81%
Maintains: Neutral
Price Target: $9$10
Current: $5.27
Upside: +89.75%
Downgrades: Sell
Price Target: $7$8
Current: $11.51
Upside: -30.50%
Maintains: Neutral
Price Target: $1.5$1.25
Current: $2.06
Upside: -39.32%
Downgrades: Neutral
Price Target: $7$3.5
Current: $2.76
Upside: +26.81%
Initiates: Outperform
Price Target: $13
Current: $9.37
Upside: +38.74%